Han Yun, Lin Veronique, Wu Fei, Hser Yih-Ing
a Department of Clinical , Social and Administrative Sciences, University of Michigan , Ann Arbor , Michigan , USA.
b Integrated Substance Abuse Treatment, University of California, Los Angeles , Los Angeles , California , USA.
Subst Use Misuse. 2016 May 11;51(6):752-62. doi: 10.3109/10826084.2016.1155604. Epub 2016 Apr 12.
Few studies have focused on Asian Americans and Pacific Islanders (AAPIs), despite indications of increasing substance abuse among AAPIs in recent years.
This prospective longitudinal study examined gender differences among AAPIs in treatment.
The study included 567 (177 women, 390 men) AAPI patients drawn from two prior studies, one with 32 community treatment programs in 13 California counties (CalTOP, 3, 9 months), and another project including 36 treatment sites in 5 California counties (TSI, 3, 12 months). Baseline and follow-up assessments utilized the Addiction Severity Index(ASI). A subset of patients was assessed at 3 and 9/12 months (n = 106).
Significant gender-related differences were observed at baseline: fewer women than men were employed or never married. More women were living with someone having alcohol and drug problems. Methamphetamine was the primary drug for women and men, followed by alcohol and heroin. Compared to AAPI men, AAPI women reported greater problem severity in family/social relationships (0.18 vs. 0.11, p <.001), employment (0.68 vs. 0.56, p <.001), and mental health (0.19 vs. 0.14, p <.01). Relative to women, AAPI men reported greater treatment satisfaction at the 3-month follow-up. Significant improvements at follow-up were observed in family, alcohol, drug, and legal domains for both genders, and in mental health for men only. Compared to AAPI men, AAPI women demonstrated significantly greater improvements in drug problems (ΔASI = 0.07, p <.05).
Gender differences revealed in this study suggest a need for a greater treatment focus on psychiatric problems for AAPI women and drug use problems for AAPI men.
尽管近年来有迹象表明亚裔美国人和太平洋岛民(AAPI)的药物滥用情况有所增加,但针对该群体的研究较少。
这项前瞻性纵向研究调查了AAPI在治疗中的性别差异。
该研究纳入了来自两项先前研究的567名AAPI患者(177名女性,390名男性),一项研究涉及加利福尼亚州13个县的32个社区治疗项目(CalTOP,为期3至9个月),另一项项目包括加利福尼亚州5个县的36个治疗地点(TSI,为期3至12个月)。基线和随访评估使用成瘾严重程度指数(ASI)。一部分患者在3个月和9/12个月时接受评估(n = 106)。
在基线时观察到显著的性别相关差异:就业或从未结婚的女性比男性少。更多女性与有酒精和药物问题的人生活在一起。甲基苯丙胺是女性和男性的主要药物,其次是酒精和海洛因。与AAPI男性相比,AAPI女性在家庭/社会关系(0.18对0.11,p <.001)、就业(0.68对0.56,p <.001)和心理健康(0.19对0.14,p <.01)方面报告的问题严重程度更高。相对于女性,AAPI男性在3个月随访时报告的治疗满意度更高。随访时,男女在家庭、酒精、药物和法律领域均有显著改善,男性仅在心理健康方面有改善。与AAPI男性相比,AAPI女性在药物问题上的改善更为显著(ΔASI = 0.07,p <.05)。
本研究揭示的性别差异表明,需要更加关注AAPI女性的精神问题和AAPI男性的药物使用问题。